Marie Paule Kieny

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi request reprint A global pandemic influenza vaccine action plan
    Marie Paule Kieny
    World Health Organization, Geneva, Switzerland
    Vaccine 24:6367-70. 2006
  2. pmc Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans
    Thomas Muller
    WHO Collaborating Centre for Rabies Surveillance and Research, Friedrich Loeffler Institute, Federal Research Institute for Animal Health, Wusterhausen, Germany
    PLoS Negl Trop Dis 3:e542. 2009
  3. ncbi request reprint [Malaria vaccines: state of advancement]
    M P Kieny
    WHO IVR, 20 Avenue Appia, CH1211 Genève 27, Suisse
    Med Trop (Mars) 63:245-6. 2003
  4. pmc Research and development of new vaccines against infectious diseases
    Marie Paule Kieny
    Initiative for Vaccine Research, World Health Organization, Avenue Appia 20, CH1211 Genève 27, Switzerland
    Am J Public Health 94:1931-5. 2004
  5. ncbi request reprint The promise of conjugate vaccines for Africa
    Marie Paule Kieny
    Initiative for Vaccine Research, World Health Organization, Av Appia 20, 1211 Geneva 27, Switzerland
    Vaccine 25:A108-10. 2007
  6. pmc Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine
    Christopher B Nelson
    Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
    Am J Public Health 97:S15-22. 2007
  7. doi request reprint WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer
    Martin Friede
    World Health Organization, Avenue Appia, 1211 Geneva, Switzerland
    Vaccine 29:A2-7. 2011
  8. doi request reprint Reducing empiricism in malaria vaccine design
    Vasee S Moorthy
    World Health Organization, Geneva, Switzerland
    Lancet Infect Dis 10:204-11. 2010
  9. ncbi request reprint Human vaccine research and development: an overview
    Marie Paule Kieny
    Initiative for Vaccine Research, World Health Organization, 20 Avenue Appia, CH1211 Genève27, Switzerland
    Vaccine 23:5705-7. 2005
  10. ncbi request reprint Comparison of immunogenicity of five MSP1-based malaria vaccine candidate antigens in rabbits
    Zarifah Hussain Reed
    Initiative for Vaccines Research, World Health Organization, Geneva, Switzerland
    Vaccine 27:1651-60. 2009

Detail Information

Publications31

  1. ncbi request reprint A global pandemic influenza vaccine action plan
    Marie Paule Kieny
    World Health Organization, Geneva, Switzerland
    Vaccine 24:6367-70. 2006
    ..2) To strengthen the engagement and collaboration of key partners and stakeholders...
  2. pmc Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans
    Thomas Muller
    WHO Collaborating Centre for Rabies Surveillance and Research, Friedrich Loeffler Institute, Federal Research Institute for Animal Health, Wusterhausen, Germany
    PLoS Negl Trop Dis 3:e542. 2009
    ....
  3. ncbi request reprint [Malaria vaccines: state of advancement]
    M P Kieny
    WHO IVR, 20 Avenue Appia, CH1211 Genève 27, Suisse
    Med Trop (Mars) 63:245-6. 2003
  4. pmc Research and development of new vaccines against infectious diseases
    Marie Paule Kieny
    Initiative for Vaccine Research, World Health Organization, Avenue Appia 20, CH1211 Genève 27, Switzerland
    Am J Public Health 94:1931-5. 2004
    ..The public, private, and philanthropic sectors need to join forces to ensure that these new or improved vaccines are fully developed and become accessible to the populations in need as quickly as possible...
  5. ncbi request reprint The promise of conjugate vaccines for Africa
    Marie Paule Kieny
    Initiative for Vaccine Research, World Health Organization, Av Appia 20, 1211 Geneva 27, Switzerland
    Vaccine 25:A108-10. 2007
    ..A review of the evidence in order to analyse how to optimize immunization schedules for conjugate vaccines is warranted...
  6. pmc Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine
    Christopher B Nelson
    Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
    Am J Public Health 97:S15-22. 2007
    ..It will remain so for the foreseeable future and until appropriate and affordable conjugate vaccines become part of national immunization programs in the region...
  7. doi request reprint WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer
    Martin Friede
    World Health Organization, Avenue Appia, 1211 Geneva, Switzerland
    Vaccine 29:A2-7. 2011
    ..This supplement of Vaccine is devoted to showcasing the interim results of the WHO initiative and the impressive progress made by the developing country manufacturers...
  8. doi request reprint Reducing empiricism in malaria vaccine design
    Vasee S Moorthy
    World Health Organization, Geneva, Switzerland
    Lancet Infect Dis 10:204-11. 2010
    ....
  9. ncbi request reprint Human vaccine research and development: an overview
    Marie Paule Kieny
    Initiative for Vaccine Research, World Health Organization, 20 Avenue Appia, CH1211 Genève27, Switzerland
    Vaccine 23:5705-7. 2005
    ..Importantly, developing countries should be empowered to participate actively in the development and introduction of new vaccines according to their national priorities...
  10. ncbi request reprint Comparison of immunogenicity of five MSP1-based malaria vaccine candidate antigens in rabbits
    Zarifah Hussain Reed
    Initiative for Vaccines Research, World Health Organization, Geneva, Switzerland
    Vaccine 27:1651-60. 2009
    ..Data from this study can assist in making decisions for further clinical development of MSP1-based candidates, and this process sets a precedent for future comparisons of malaria vaccine candidates...
  11. ncbi request reprint Malaria vaccine development: progress and challenges
    Z H Reed
    Initiative for Vaccine Research, World Health Organization, Department of Immunizations, Vaccines and Biologicals, 20 Avenue Appia, CH 1211 Geneva, Switzerland
    Curr Mol Med 6:231-45. 2006
    ..Therefore, it is critical that the main challenges to malaria vaccine development be unambiguously identified and collectively addressed...
  12. ncbi request reprint Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand
    J Hombach
    Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
    Vaccine 23:2689-95. 2005
    ....
  13. ncbi request reprint 4th meeting on Novel Adjuvants Currently in/close to Human Clinical Testing World Health Organization -- organisation Mondiale de la Santé Fondation Mérieux, Annecy, France, 23-25, June 2003
    J Richard Pink
    World Health Organization IVR, Geneva, Switzerland
    Vaccine 22:2097-102. 2004
  14. doi request reprint Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets
    Jeffrey Partridge
    Initiative for Vaccine Research, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland
    Vaccine 28:4709-12. 2010
    ....
  15. ncbi request reprint Immunization safety priority project at the World Health Organization
    Philippe Duclos
    Department of Vaccines and Biologicals, Health Technology and Pharmaceuticals, World Health Organization Geneva, 20 Avenue Appia, CH 1211 Geneva 27, Switzerland
    Semin Pediatr Infect Dis 14:233-9. 2003
    ..The project emphasizes the importance of advocating safety and building capacity at national levels...
  16. doi request reprint Research agenda for mass gatherings: a call to action
    John S Tam
    Initiative for Vaccine Research, Family, Women s and Children s Health Cluster, WHO, Geneva, Switzerland
    Lancet Infect Dis 12:231-9. 2012
    ..Implementation of the proposed research topics would be expected to provide benefits over the medium to long term in planning for MGs...
  17. ncbi request reprint Third meeting on Novel Adjuvants Currently in or Close to Clinical Testing World Health Organization--Organisation Mondiale de la Santé, Fondation Mérieux, Annecy, France, 7-9 January 2002
    Howard Engers
    World Health Organization IVR, Avenue Appia 20, CH 1211, Geneva 27, Switzerland
    Vaccine 21:3503-24. 2003
  18. doi request reprint Cholera in disasters: do vaccines prompt new hopes?
    Claire Lise Chaignat
    Global Task Force on Cholera Control, Department of Neglected Tropical Diseases, Communicable Diseases Cluster, World Health Organization, 20, Av Appia, 1211 Geneva 27, Switzerland
    Expert Rev Vaccines 7:431-5. 2008
    ..Following these two campaigns, WHO recommendations on the use of oral cholera vaccines in complex emergencies were issued in 2006...
  19. ncbi request reprint First generation leishmaniasis vaccines: a review of field efficacy trials
    Sassan Noazin
    World Health Organization, CH1211, Geneva 27, Switzerland
    Vaccine 26:6759-67. 2008
    ..To provide a collective view, this review discusses the methods and findings of field efficacy trials of first generation leishmaniasis vaccine clinical trials conducted in the Old and New Worlds...
  20. ncbi request reprint A review of human vaccine research and development: malaria
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 25:1567-80. 2007
    ..This article attempts to summarize the state of the art of malaria vaccine development...
  21. ncbi request reprint Development and evaluation of influenza pandemic vaccines
    Iain Stephenson
    Lancet Infect Dis 6:71-2. 2006
  22. doi request reprint Report of the 4th meeting on the "Evaluation of pandemic influenza prototype vaccines in clinical trials." World Health Organization, Geneva, Switzerland, 14-15 February 2008
    Marc Girard
    University Paris Diderot, Lyon, France
    Vaccine 26:4975-7. 2008
  23. doi request reprint Report of the third meeting on "influenza vaccines that induce broad spectrum and long-lasting immune responses", World Health Organization, Geneva, Switzerland, 3-4 December 2007
    Marc P Girard
    University Paris Diderot, Lyon, France
    Vaccine 26:2443-50. 2008
  24. ncbi request reprint A review of vaccine research and development: meningococcal disease
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 24:4692-700. 2006
    ..However, effective global prevention of meningococcal disease will not be achievable without the development of a vaccine against Group B meningitis, for which outer membrane protein vaccines are under development...
  25. ncbi request reprint Report of the second meeting on the development of influenza vaccines that induce broad-spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 6-7 December 2005
    Alan W Hampson
    Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands
    Vaccine 24:4897-4900. 2006
    ..The main conclusions and recommendations from this consultation are presented below...
  26. ncbi request reprint A review of vaccine research and development: the human immunodeficiency virus (HIV)
    Marc P Girard
    University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 24:4062-81. 2006
    ..This article reviews the state of the art in HIV vaccine development, summarizes the results obtained so far and discusses the challenges to be met in the development of the various vaccine candidates...
  27. ncbi request reprint A review of vaccine research and development: human enteric infections
    Marc P Girard
    University Paris 7, UFR Biochemistry, 39 rue Seignemartin, 69008 Lyon, France
    Vaccine 24:2732-50. 2006
    ..This article reviews the state of the art in vaccine R&D against human viral and bacterial enteric infections of public health importance...
  28. ncbi request reprint The impact of globalization on vaccine development and availability
    Julie B Milstien
    Center for Vaccine Development, Department of Geographic Medicine, University of Maryland School of Medicine, USA
    Health Aff (Millwood) 25:1061-9. 2006
    ..All of these forces can affect, either positively and negatively, the development and availability of vaccines. Harnessing these will be a challenge for policymakers and immunization stakeholders...
  29. ncbi request reprint A review of vaccine research and development: human acute respiratory infections
    Marc P Girard
    University Paris 7, UFR Biochemistry, 39 rue Seignemartin, FR 69008 Lyon, France
    Vaccine 23:5708-24. 2005
    ..This article reviews the state of the art in vaccine R&D against ARIs and attempts to address these basic public health questions...
  30. ncbi request reprint Different approaches to influenza vaccination
    Keiji Fukuda
    N Engl J Med 355:2586-7. 2006
  31. ncbi request reprint Development of vaccines against influenza H5
    Iain Stephenson
    Lancet Infect Dis 6:458-60. 2006